✉news HealthMedicine first seen 2 h ago, last 2 h ago, peak #36
Mount Sinai to test novel liquid radioembolic agent for brain tumors
Original: Mount Sinai announces collaborative research agreement to evaluate novel liquid radioembolic agent for brain tumors
Mount Sinai has announced a collaborative research agreement to evaluate a novel liquid radioembolic agent for treating brain tumors. The therapy would deliver radiation directly to tumor tissue in liquid form, an approach being explored for cancers that are difficult to treat surgically. Details on the partner institution, trial design and timeline have not yet been released, and clinical results remain pending.
Why now: The announcement is new and of interest to oncology researchers and patients following advances in brain tumor treatment.
Evidence
- Mount Sinai announces collaborative research agreement to evaluate novel liquid radioembolic agent for brain tumors · EurekAlert! Science News Releases
API: https://socialmediatrends-api.osmike.com/v1/trends/272524